Not to mention that if they don't find a way to speed up their research and clinical trial process, they are going to fall woefully behind all the other psychedelic companies in the sector. It has take them over a year to do phase 3 for an oral medication. If they take 5-7 years to do some shroom trials, they are doomed. Other companies will beat them to the punch with similar medications. In the pharma industry, it's not always about having the best product, it's often about being first.